ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $141,605 | +73.4% | 5,270 | +130.1% | 0.00% | 0.0% |
Q2 2023 | $81,661 | +160019.6% | 2,290 | +14.2% | 0.00% | – |
Q1 2023 | $51 | -83.6% | 2,005 | -73.8% | 0.00% | -100.0% |
Q4 2022 | $311 | -99.9% | 7,667 | +1.9% | 0.00% | 0.0% |
Q3 2022 | $253,000 | -1.9% | 7,526 | +2.8% | 0.00% | 0.0% |
Q2 2022 | $258,000 | +24.0% | 7,324 | +61.9% | 0.00% | +100.0% |
Q1 2022 | $208,000 | -41.4% | 4,524 | -32.8% | 0.00% | -66.7% |
Q4 2021 | $355,000 | -42.6% | 6,734 | -32.0% | 0.00% | -25.0% |
Q3 2021 | $618,000 | -13.8% | 9,904 | +14.4% | 0.00% | 0.0% |
Q2 2021 | $717,000 | +40.3% | 8,658 | +12.3% | 0.00% | +33.3% |
Q1 2021 | $511,000 | -11.9% | 7,708 | +2.0% | 0.00% | -25.0% |
Q4 2020 | $580,000 | +147.9% | 7,558 | +39.1% | 0.00% | +100.0% |
Q3 2020 | $234,000 | +69.6% | 5,435 | +70.6% | 0.00% | +100.0% |
Q2 2020 | $138,000 | -45.5% | 3,185 | -63.8% | 0.00% | -66.7% |
Q1 2020 | $253,000 | -65.2% | 8,810 | -23.0% | 0.00% | -50.0% |
Q4 2019 | $726,000 | +2403.4% | 11,440 | +1021.6% | 0.01% | – |
Q3 2019 | $29,000 | +107.1% | 1,020 | +96.2% | 0.00% | – |
Q2 2019 | $14,000 | +40.0% | 520 | 0.0% | 0.00% | – |
Q1 2019 | $10,000 | +66.7% | 520 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -40.0% | 520 | 0.0% | 0.00% | – |
Q3 2018 | $10,000 | +42.9% | 520 | -86.3% | 0.00% | – |
Q1 2017 | $7,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |